LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m1baecb82dc9db35adf2965f934f732ec

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Define the updated definition of pulmonary hypertension (PH), (2) Review the common diagnostic rests for PH, (3) Describe the risk assessment protocols used to treat PH.  

FACULTY DISCLOSURE: Chetan Naik, MD, is a speaker for  Janssen Pharmaceuticals.

All relevant financial relationships have been mitigated.

PLANNER DISCLOSURE: Jay Herd, MD and Dipesh Bista, MD, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Mary Biggers at Mary.Biggers@BSWHealth.org